Facebook
Twitter
Telegram
Report an ErrorMarker Therapeutics Financial Statements 2011-2024 | MRKR
Annual Financial Statements Marker Therapeutics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
16.1 M | 7.27 M | 90 M | 122 M | 106 M | 35.1 M | 28.9 M | 25.9 M | 2.78 M | 2.27 M | 10.5 M | 7.36 M |
Shares |
8.35 M | 7.65 M | 46.9 M | 45.6 M | 19.1 M | 9.45 M | 6.89 M | 3.66 M | 1.29 M | 94.7 K | 54.6 K | 38.3 K |
Historical Prices |
1.93 | 0.95 | 1.45 | 2.88 | 5.55 | 3.92 | 3.88 | 7.2 | 3.36 | 24 | 144 | 180 |
Net Income |
-29.9 M | -41.9 M | -28.7 M | -21.4 M | -148 M | -11 M | -2.46 M | -34.1 M | -30.9 M | -5.53 M | -5.86 M | -2.03 M |
Revenue |
9.01 M | 1.24 M | 467 K | 213 K | 206 K | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | 467 | - | - | - | - | - | - | - | - | - |
Operating Income |
-29.9 M | -39.5 M | -28.9 M | -22.5 M | -148 M | -11.5 M | -8.49 M | -6.16 M | -3.37 M | -2.66 M | - | -3.32 M |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-27.2 M | -37.3 M | -27.8 M | -22.2 M | -148 M | -12 M | -8.26 M | -6.16 M | -3.37 M | -2.66 M | -5.58 M | -2.64 M |
Operating Expenses |
39 M | 40.7 M | 29.4 M | 22.7 M | 148 M | 11.5 M | 8.26 M | 6.16 M | 3.37 M | 2.66 M | 5.48 M | 2.64 M |
General and Administrative Expenses |
12.8 M | 12.9 M | 10.5 M | 9.98 M | 24.4 M | 6.41 M | 4.69 M | 4.45 M | 3.18 M | 2 M | 4.42 M | 2.43 M |
All numbers in USD currency
Quarterly Income Statement Marker Therapeutics
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
8.9 M | 8.9 M | 8.83 M | 8.8 M | 8.72 M | 8.4 M | 8.36 M | 8.36 M | 8.31 M | 83.1 M | 83.1 M | 83 M | 56.5 M | 50.7 M | 46.9 M | 46.6 M | 46.1 M | 45.7 M | 45.7 M | 45.5 M | 45.5 M | 45.4 M | 13.7 M | 11.8 M | 10.6 M | 10.6 M | 10.2 M | 8.58 M | 8.43 M | 8.4 M | 7.28 M | 5.94 M | 5.88 M | 5.88 M | 4.05 M | 33.5 M | 27.6 M | 20.3 M | 17.3 M | 15.5 M | 7.63 M | 1.47 M | 1.27 M | 1 M | 807 K | 764 K | 76.4 M | 62 M | 52.5 M | 52.1 M | 52.1 M | 46.7 M | 52.1 M |
Net Income |
-2.39 M | - | -2.98 M | 2.52 M | -4.97 M | - | -6.92 M | -9.24 M | -9.91 M | - | -12.4 M | -10.9 M | -8.78 M | - | -7.37 M | -6.34 M | -6.49 M | - | -5.46 M | -5.57 M | -5.32 M | - | -4.39 M | -4.81 M | -3.2 M | - | -3.99 M | -1.89 M | -2.42 M | - | -2.1 M | 5.97 M | -4.75 M | - | 28.5 M | -60.2 M | -701 K | - | -1.57 M | 753 K | -29.7 M | - | -2.06 M | -871 K | -85.1 M | - | - | -2.54 M | -599 K | - | -844 K | -404 K | -1.27 M |
Revenue |
1.24 M | - | 258 K | 763 K | 1.23 M | - | 1 M | 791 K | 964 K | - | - | - | - | - | - | 467 K | - | - | - | - | - | - | - | 206 K | - | - | 183 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-2.55 M | - | -3.2 M | -4.13 M | -4.31 M | - | -5.83 M | -5.27 M | -9.79 M | - | -10 M | -10.9 M | -8.78 M | - | -7.38 M | -6.36 M | -6.64 M | - | -5.65 M | -5.87 M | -5.64 M | - | -4.43 M | -4.67 M | -3.2 M | - | -3.99 M | -2.39 M | -2.42 M | - | -2.72 M | -2.43 M | -1.75 M | - | -1.74 M | -1.14 M | -1.03 M | - | - | - | - | - | -313 K | -675 K | -1.12 M | - | -797 K | -3.14 M | -672 K | - | -905 K | -701 K | -1.1 M |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | - | - | -3.49 M | - | -3.85 M | -4.11 M | -9.22 M | - | -8.44 M | -9.88 M | -8.28 M | - | -7.1 M | -6.23 M | -6.61 M | - | -5.58 M | -5.83 M | -5.63 M | - | -4.43 M | -4.67 M | -3.2 M | - | -3.99 M | -2.39 M | -2.42 M | - | -2.72 M | -2.43 M | -1.75 M | - | -1.74 M | -1.14 M | -1.03 M | - | - | - | - | - | -313 K | -675 K | -902 K | - | -797 K | -3.14 M | -672 K | - | -905 K | -701 K | -1.1 M |
Operating Expenses |
3.79 M | - | 3.46 M | 4.9 M | 5.54 M | - | 6.83 M | 6.06 M | 10.8 M | - | 10 M | 10.9 M | 8.78 M | - | 7.38 M | 6.82 M | 6.64 M | - | 5.65 M | 5.87 M | 5.64 M | - | 4.43 M | 4.88 M | 3.2 M | - | 4.17 M | 2.39 M | 2.42 M | - | 2.72 M | 2.43 M | 1.75 M | - | 1.74 M | - | - | - | 1.38 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
1.22 M | - | 1.41 M | 2.52 M | 2.17 M | - | 3.23 M | 3.14 M | 3.73 M | - | 3.24 M | 3.56 M | 3.14 M | - | 2.57 M | 2.55 M | 2.83 M | - | 2.54 M | 2.72 M | 2.81 M | - | 2.55 M | 3.05 M | 1.6 M | - | 2.55 M | 1.19 M | 1.43 M | - | 1.61 M | 1.18 M | 768 K | - | 769 K | 937 K | 419 K | - | 1.35 M | 488 K | 1.16 M | - | 70.5 K | 88.1 K | 4.7 M | - | 268 K | 468 K | 142 K | - | 23.9 K | 37 K | 5.12 K |
All numbers in USD currency